MarketPulse
S

$SPRC

1 article found
1 positive
0 negative
0 neutral
BenzingaBenzinga··Na

SciSparc's NeuroThera Labs to Acquire Majority Stake in Quantum Clinical Trials Pioneer

SciSparc's NeuroThera Labs acquires 54% of quantum clinical trials company CliniQuantum for $9.46M in stock plus $2.5M earn-out, closing by March 2026.
SPRCacquisitionclinical trials